IVAD protocol

chemotherapy protocol consisting of above cpds; used in treatment of Ewing's sarcoma and DSRCT (desmoplastic small round-cell tumor)

Also Known As:

P6 protocol

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Therapy Context: Research Results

Therapeutics: 1158551
- Drug Therapy: 293145
  - Combination Drug Therapy: 12066
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - IVAD protocol: 3
  - Antineoplastic Protocols: 55
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - IVAD protocol: 3
- Clinical Protocols
  - Antineoplastic Protocols: 55
    - Antineoplastic Combined Chemotherapy Protocols: 35
      - IVAD protocol: 3
Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Polycyclic Aromatic Hydrocarbons: 2020
        Naphthalenes: 18
        Tetrahydronaphthalenes: 1
        Podophyllotoxin: 562
        Etoposide: 10706
        IVAD protocol: 3
        Naphthacenes
        Anthracyclines: 9423
        Daunorubicin: 2641
        Doxorubicin: 35390
        IVAD protocol: 3
  - Halogenated Hydrocarbons: 42
    - Mustard Compounds: 3
      - Nitrogen Mustard Compounds: 2
        Phosphoramide Mustards: 5
        Cyclophosphamide: 25473
        Ifosfamide: 3556
        IVAD protocol: 3
        IVAD protocol: 3
- Organophosphorus Compounds: 300
  - Phosphoramides: 8
    - Phosphoramide Mustards: 5
      - Cyclophosphamide: 25473
        Ifosfamide: 3556
        IVAD protocol: 3
        IVAD protocol: 3
Polycyclic Compounds: 6
- Polycyclic Aromatic Hydrocarbons: 2020
  - Naphthalenes: 18
    - Tetrahydronaphthalenes: 1
      - Podophyllotoxin: 562
        Etoposide: 10706
        IVAD protocol: 3
  - Naphthacenes
    - Anthracyclines: 9423
      - Daunorubicin: 2641
        Doxorubicin: 35390
        IVAD protocol: 3
Carbohydrates: 22023
- Glycosides: 2119
  - Aminoglycosides: 5131
    - Anthracyclines: 9423
      - Daunorubicin: 2641
        Doxorubicin: 35390
        IVAD protocol: 3
  - Glucosides: 639
    - Etoposide: 10706
      - IVAD protocol: 3
Heterocyclic Compounds: 198

Experts

1.	Aleshawi, Abdelwahab J: 1 article (11/2019)
2.	Alhowary, Ala'a: 1 article (11/2019)
3.	Altal, Omar F: 1 article (11/2019)
4.	Tashtush, Nour A: 1 article (11/2019)
5.	Cardesa, Teresa: 1 article (07/2011)
6.	Cruz, Ofelia: 1 article (07/2011)
7.	Galván, Patricia: 1 article (07/2011)
8.	Huguet, Ramon: 1 article (07/2011)
9.	Mora, Jaume: 1 article (07/2011)
10.	Parareda, Andreu: 1 article (07/2011)

Related Diseases

1.	Primitive Neuroectodermal Tumors (PNET) 02/01/2001 - "Twenty-one unselected MSKCC patients with newly diagnosed ES/PNET metastatic to bone/BM received the "P6" protocol which includes cycles of cyclophosphamide (4.2 g/m(2))/doxorubicin (75 mg/m(2))/vincristine and cycles of ifosfamide (9 g/m(2))/etoposide (500 mg/m(2)). "
2.	Ewing Sarcoma (Sarcoma, Ewing) 07/15/2011 - "Reported overall survival (OS) rates of patients with localized Ewing sarcoma family of tumors (ESFT) are >80% when treated with the MSKCC P6 protocol. " 07/15/2011 - "Treatment of Ewing sarcoma family of tumors with a modified P6 protocol in children and adolescents."
3.	Neoplasms (Cancer) 07/15/2011 - "Reported overall survival (OS) rates of patients with localized Ewing sarcoma family of tumors (ESFT) are >80% when treated with the MSKCC P6 protocol. " 07/15/2011 - "Treatment of Ewing sarcoma family of tumors with a modified P6 protocol in children and adolescents."
4.	Infections 11/14/2019 - "After the second cycle of the P6 Protocol, which included seven courses of chemotherapy, the patient developed a severe and fatal infection. "

Related Drugs and Biologics

1.	Vincristine (Oncovin)
2.	Ifosfamide
3.	Etoposide (VP 16)
4.	Doxorubicin (Adriamycin)
5.	Cyclophosphamide (Cytoxan)

Related Therapies and Procedures

1.	Drug Therapy (Chemotherapy)